We have previously published that the clinical-genomic risk score CAPRA&PDE4D5/7/9, which is a combination model of the CAPRA score with the expression levels of the respective PDE4D transcripts, is associated with prostate cancer progression after surgical removal of the prostate. The gene discussed is PDE4D; the disease is prostate carcinoma.